Shared on11 Sep 25Fair value Decreased 0.98%
With both Ardent Health’s future P/E and consensus revenue growth forecasts holding steady, analysts have made only a marginal downward revision in their fair value estimate, lowering the price target from $19.27 to $19.08. What's in the News Ardent Health reaffirmed full-year 2025 earnings guidance, projecting total revenue between $6.2 billion and $6.45 billion and diluted EPS in the range of $1.73 to $2.01.